The earlier onset of puberty in girls has been linked to increased risks of breast cancer, cardiovascular disease and diabetes.

ProRx Pharma, the leading health and wellness 503B outsourcing facility, today announced the addition of six new injectable products designed to support the rising demand for preventive care: ...

The National Institutes of Health (NIH) has pumped millions of tax dollars into a years-long research project to study the ...

There is no cure, and current treatment relies on pain relief and hormonal treatment, with injectable gonadotropin-releasing hormone (GnRH) agonists and surgery generally used as second-line options.

Other medications—Other medications that are less commonly used to treat abnormal uterine bleeding include gonadotropin-releasing hormone agonists (sometimes called GnRH agonists), danazol ...

We explore the current guidance for osteoporosis screening in men, as well as barriers to access for both clinicians and ...

This overview focuses on the recent developments in the safety and efficacy of the levonorgestrel-releasing intrauterine system (LNG-IUS) on established indications, namely contraception ...

Uttarakhand Board Results 2025: The result will be available on the official website, starting 11am. The board will announce the result through a press conference, during which it will also share ...

The treatment strategy for congenital adrenal hyperplasia is burdensome and had not changed in more than 70 years until the ...

Yes, I do think we need non-glucocorticoid forms of therapy to treat 21-hydroxylase deficiency congenital adrenal hyperplasia.The most common form of congenital adrenal hyperplasia (CAH) is a ...

They also help regulate blood pressure, maintain the right levels of electrolytes like sodium and potassium, and support the production of red blood cells by releasing a hormone called erythropoietin.